Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI3022

MHC haplotype-dependent regulation of MOG-induced EAE in rats.

R Weissert, E Wallström, M K Storch, A Stefferl, J Lorentzen, H Lassmann, C Linington, and T Olsson

Neuroimmunology Unit, Center of Molecular Medicine L8:04, Karolinska Hospital, S-17176 Stockholm, Sweden. robert.weissert@uni-tuebingen.de

Find articles by Weissert, R. in: PubMed | Google Scholar

Neuroimmunology Unit, Center of Molecular Medicine L8:04, Karolinska Hospital, S-17176 Stockholm, Sweden. robert.weissert@uni-tuebingen.de

Find articles by Wallström, E. in: PubMed | Google Scholar

Neuroimmunology Unit, Center of Molecular Medicine L8:04, Karolinska Hospital, S-17176 Stockholm, Sweden. robert.weissert@uni-tuebingen.de

Find articles by Storch, M. in: PubMed | Google Scholar

Neuroimmunology Unit, Center of Molecular Medicine L8:04, Karolinska Hospital, S-17176 Stockholm, Sweden. robert.weissert@uni-tuebingen.de

Find articles by Stefferl, A. in: PubMed | Google Scholar

Neuroimmunology Unit, Center of Molecular Medicine L8:04, Karolinska Hospital, S-17176 Stockholm, Sweden. robert.weissert@uni-tuebingen.de

Find articles by Lorentzen, J. in: PubMed | Google Scholar

Neuroimmunology Unit, Center of Molecular Medicine L8:04, Karolinska Hospital, S-17176 Stockholm, Sweden. robert.weissert@uni-tuebingen.de

Find articles by Lassmann, H. in: PubMed | Google Scholar

Neuroimmunology Unit, Center of Molecular Medicine L8:04, Karolinska Hospital, S-17176 Stockholm, Sweden. robert.weissert@uni-tuebingen.de

Find articles by Linington, C. in: PubMed | Google Scholar

Neuroimmunology Unit, Center of Molecular Medicine L8:04, Karolinska Hospital, S-17176 Stockholm, Sweden. robert.weissert@uni-tuebingen.de

Find articles by Olsson, T. in: PubMed | Google Scholar

Published September 15, 1998 - More info

Published in Volume 102, Issue 6 on September 15, 1998
J Clin Invest. 1998;102(6):1265–1273. https://doi.org/10.1172/JCI3022.
© 1998 The American Society for Clinical Investigation
Published September 15, 1998 - Version history
View PDF
Abstract

Experimental autoimmune encephalomyelitis (EAE) induced in the rat by active immunization with myelin-oligodendrocyte-glycoprotein (MOG) is mediated by synergy between MOG-specific T cells and demyelinating MOG-specific antibody responses. The resulting disease is chronic and displays demyelinating central nervous system (CNS) pathology that closely resembles multiple sclerosis. We analyzed major histocompatibility complex (MHC) haplotype influences on this disease. The MHC haplotype does not exert an all-or-none effect on disease susceptibility. Rather, it determines the degree of disease susceptibility, recruitment of MOG-specific immunocompetent cells, clinical course, and CNS pathology in a hierarchical and allele-specific manner. Major haplotype-specific effects on MOG-EAE map to the MHC class II gene region, but this effect is modified by other MHC genes. In addition, non-MHC genes directly influence both disease and T cell functions, such as the secretion of IFN-gamma. Thus, in MOG-EAE, allelic MHC class II effects are graded, strongly modified by other MHC genes, and overcome by effects of non-MHC genes and environment.

Version history
  • Version 1 (September 15, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts